This Article Full Text Full Text (PDF) All Versions of this Article: 39/4/1269    most recent STROKEAHA.107.498923v1 Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Permissions Google Scholar Articles by Ponce, J. Articles by Gasull, T. PubMed PubMed Citation Articles by Ponce, J. Articles by Gasull, T. Pubmed/NCBI databases Compound via MeSH Substance via MeSH Hazardous Substances DB CHOLESTEROL Related Collections Neuroprotectors Lipids Lipid and lipoprotein metabolism Ischemic biology - basic studies Ion channels/membrane transport

(Stroke. 2008;39:1269.)
© 2008 American Heart Association, Inc.

Original Contributions

Simvastatin Reduces the Association of NMDA Receptors to Lipid Rafts

A Cholesterol-Mediated Effect in Neuroprotection

Jovita Ponce, BS; Natalia Pérez de la Ossa, MD; Olivia Hurtado, PhD; Mónica Millan, MD; Juan F. Arenillas, MD, PhD; Antonio Dávalos, MD, PhD Teresa Gasull, PhD

From Neuroscience Basic Research Lab (J.P., T.G.) and Department of Neurosciences (J.P., N.P.O., M.M., J.A., A.D., T.G.), Fundació Institut d’Investigació en Ciències de la Salut Germans Trias i Pujol, Badalona, Spain. Universitat Autònoma de Barcelona, Badalona, Spain; Departamento de Farmacología (O.H.), Facultad de Medicina, Universidad Complutense de Madrid, Madrid, Spain.

Correspondence to Teresa Gasull, Neuroscience Basic Research Lab, Fundació Institut d’Investigació en Ciències de la Salut Germans Trias i Pujol, Ctra. de Can Ruti, Camí de les escoles s/n, 08916, Badalona, Barcelona, Spain. E-mail teresagasull{at}yahoo.com

Background and Purpose— Excess brain extracellular glutamate induced by cerebral ischemia leads to neuronal death, mainly through overactivation of N-methyl-D-aspartate (NMDA) receptors. The cholesterol-lowering drugs statins have been reported to protect from NMDA-induced neuronal death but, so far, the mechanism underlying this protection remains unclear. Because NMDA receptors have been reported to be associated with the cholesterol-rich membrane domains known as lipid rafts, we have investigated the effect of treatments that deplete cholesterol levels on excitotoxicity and on association of NMDA receptors to lipid rafts.

Methods— Primary neuronal cultures were pretreated with inhibitors of cholesterol synthesis and cholesterol, and NMDA-induced cell death was determined by measuring release of lactate dehydrogenase. Lipid raft fractions were isolated and Western blots were performed.

Results— Treatment with the inhibitors of cholesterol synthesis simvastatin, which inhibits the first step of cholesterol synthesis, or AY9944, which inhibits the last step of cholesterol synthesis, protected neurons from NMDA-induced neuronal death by 70% and 54%, respectively. Treatment with these compounds reduced neuronal cholesterol levels by 35% and 13%, respectively. Simvastatin and AY9944 reduced the association of the subunit 1 of NMDA receptors (NMDAR1) to lipid rafts by 42% and 21%, respectively, and did not change total expression of NMDAR1. Addition of cholesterol reduced neuroprotection by statins and AY9944, and partially reverted the effect of simvastatin on the association of NMDAR1 to lipid rafts.

Conclusions— These data demonstrate that reduction of cholesterol levels protects from NMDA-induced neuronal damage probably by reducing the association of NMDA receptors to lipid rafts.

Key Words: excitotoxicity • ischemia lipids • statins